PTGX: Protagonist Therapeutics, Inc. Kompaniya qiymatining sof foydaga nisbati
Bozor kapitalizatsiyasining foyda ko'rsatkichiga nisbati aktivning baholash tendentsiyasini aks ettiradi, bunda 25.30 qiymati joriy raqamni ifodalaydi. Protagonist Therapeutics (PTGX) kompaniyasining natijalari barqaror naqd zaxiralar fonida klinik sinovlar muddatlari va hamkorlik to'lovlariga bog'liqdir. Uning innovatsion peptid yechimlari bazasi sanoat gigantlarining portfellari tarkibiga kiritilmoqda. O'sish oral dori formulalari va psoriaz davolash bo'yicha J&J bilan hamkorlik orqali ta'minlanmoqda.
%20P%2FE%20multiplikatori&width=1200&height=400&colorIndex=0&v=mwg3sw3k.w4s-7di3ke8&start=20220704&end=20261114&filename=GURU_Markets_-_PTGX_-_Protagonist-Therapeutics_-_PE-Multiple "PTGX: Protagonist Therapeutics Biznesning o‘zini qoplash muddati 04.07.2022 - 14.11.2026 | 👁️GURU.Markets👁️")
Protagonist Therapeutics Inc (PTGX) kompaniyasining tahliliy kesimlari
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Protagonist Therapeutics|PTGX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati Protagonist Corp|PTGX - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati Protagonist|PTGX - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz Protagonist Therapeutics|Kritik likvidlik koeffitsiyenti protagonist-inc.com
- foyda va bozor multiplikatorlari tafsilotlari:
PTGX - Kompaniyaning sof foydasi|Kutilayotgan sof daromad Protagonist Therapeutics|PTGX - Narxning foydaga nisbati|Prognoz qilingan narx-foyda nisbati Protagonist Therapeutics, Inc.|PTGX - Narx-foyda va o‘sish multiplikatori|Korxona qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati koeffitsiyenti Protagonist|PTGX - EBITDA operatsion foydasi|Bir aksiya uchun sof foyda (EPS TTM) Protagonist Therapeutics|PTGX - Bir aksiya uchun sof foyda (EPS TTM)|Sirpanuvchi yil uchun bir aksiya uchun sof foyda o'sishi protagonist-inc.com|PTGX - Joriy yilda bir aksiya uchun foyda o'sishi|Keyingi yilda bir aksiya uchun sof foydaning kutilayotgan o'sishi Protagonist Therapeutics
- realizatsiya hajmi va tushum ko'rsatkichlari:
Kompaniyaning har tomonlama tahlili:protagonist-inc.com PTGX
Fundamental xatarlarni minimallashtirish bozor kapitalizatsiyasining sof foydaga nisbatini tahlil qilishni talab etadi, bu esa bir dollar foyda narxini aniqlash va eyforiya cho'qqisi paytida ortiqcha to'lov qilishdan qochish imkonini beradi. Peptid dori vositalari uchun noyob patentlarga ega bo'lgan Protagonist Therapeutics (PTGX) uchun kompaniyaning P/E grafigi kelajakdagi barqaror pul oqimlari bo'yicha kutishlarning tebranishlarini yumshatgan holda, adolatli qiymat koridorini aniq namoyish etadi.
Muhim raqobatchilar
P/E multiplikatori argenx.com|Narx-foyda koeffitsiyenti BNTX (BioNTech)|ABVX (ABIVAX) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ADMA (ADMA Bio)|Biznesning o‘zini qoplash muddati Immunovant Therapeutics (IMVT)|KNSA - Narxning foydaga nisbati|grifols.com (GRFS) - Narx-foyda koeffitsiyenti|Adaptive Biotechnologies Corporation (ADPT) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Celldex Therapeutics Inc|Narx-foyda koeffitsiyenti AUPH|P/E multiplikatori BioCryst Corp|Narxning foydaga nisbati Vera Therapeutics, Inc. (VERA)|dianthustx.com - Narx-foyda multiplikatori|P/E multiplikatori PHVS (Pharvaris)|AbCellera Corp (ABCL) - Kapitalizatsiyaning foydaga nisbati|TRML - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati PGEN|Pharming Group N.V. (PHAR) - Narxning foydaga nisbati|nektar.com - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Upstream Bio|Kapitalizatsiyaning foydaga nisbati Zenas Bio ZBIO|Narx-foyda koeffitsiyenti IMNM (Immunome Corp)|Bozor narxining sof foydaga nisbati GOSS|P/E multiplikatori KALV (KalVista Pharmaceuticals)|P/E multiplikatori septerna.com SEPN|Pieris Pharmaceuticals, Inc. - P/E multiplikatori|Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti Savara Inc (SVRA)|Rigel Pharmaceuticals Inc (RIGL) - Narxning foydaga nisbati|Kapitalizatsiyaning foydaga nisbati AnaptysBio Inc. (ANAB)|Narxning foydaga nisbati Astria Therapeutics|Narx-foyda multiplikatori ENGN (engene.com)|P/E multiplikatori RAPT|Biznesning o‘zini qoplash muddati aerovatetx.com|Narxning foydaga nisbati Aclaris ACRS|Biznesning o‘zini qoplash muddati Kyverna Therapeutics, Inc (KYTX)|TLSA: Narx-foyda koeffitsiyenti|cabalettabio.com - Bozor narxining sof foydaga nisbati|VTYX (Ventyx Biosciences, Inc.) - Narx-foyda koeffitsiyenti|Theratechnologies, Inc. - Kompaniya qiymatining sof foydaga nisbati|Narx-foyda koeffitsiyenti AVTX|ELDN (Eledon Pharmaceuticals, Inc) - Bozor narxining sof foydaga nisbati|P/E multiplikatori AGEN|CLYM (climbbio.com) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ZURA (Zura Bio)|aTyr Pharma Inc (ATYR) - Kapitalizatsiyaning foydaga nisbati|ADAG - Narxning foydaga nisbati|Kompaniya qiymatining sof foydaga nisbati IMA (ImageneBio Inc)|STTK: P/E multiplikatori|Equillium (EQ) - P/E multiplikatori|Narxning foydaga nisbati Connect Biopharma Holdings|Immunic Inc - Kapitalizatsiyaning sof foydaga nisbati|P/E multiplikatori ATRA|IFRX - Kapitalizatsiyaning foydaga nisbati|X4 Pharmaceuticals - Narx-foyda koeffitsiyenti|P/E multiplikatori Adicet Bio Inc. ACET|CELU: Narx-foyda koeffitsiyenti|INmune Bio Inc - Bozor narxining sof foydaga nisbati|BRNS: P/E multiplikatori|KZR - Biznesning o‘zini qoplash muddati|SABS (SAB Biotherapeutics) - P/E multiplikatori|Narx-foyda koeffitsiyenti akaritx.com (AKTX)|Narxning foydaga nisbati Enlivex Therapeutics (ENLV)|Biznesning o‘zini qoplash muddati q32bio.com|Narxning foydaga nisbati GeoVax Labs Inc GOVX|EDSA (Edesa Biotech Corp) - Kapitalizatsiyaning sof foydaga nisbati|IBIO: Narx-foyda koeffitsiyenti|Carisma Therapeutics - Bozor narxining sof foydaga nisbati|XTLB: P/E multiplikatori|Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti Bolt Biotherapeutics, Inc. BOLT|Narx-foyda koeffitsiyenti HCWB|Narx-foyda multiplikatori APVO (Aptevo)|Narxning foydaga nisbati AIM ImmunoTech Inc. (AIM)|ADTX: Kapitalizatsiyaning sof foydaga nisbati|P/E multiplikatori GRI (GRI Bio)|Kompaniya qiymatining sof foydaga nisbati XRTX|ReShape Lifesciences - P/E multiplikatori|REVB - P/E multiplikatori|Indaptus Therapeutics (INDP) - Narxning foydaga nisbati|scinai.com - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati CalciMedica Inc|Narx-foyda koeffitsiyenti Affimed Therapeutics (AFMD)|P/E multiplikatori ALLK|P/E multiplikatori hookipapharma.com (HOOK)|IGM Biosciences - Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati ITOS|Ocean Biomedical - P/E multiplikatori|Biznesning o‘zini qoplash muddati TC BioPharm (Holdings) Plc TCBP|Third Harmonic Bio, Inc (THRD) - Narxning foydaga nisbati
